SUBSTITUIERTE XANTHINDERIVATE

European patent · EP3199203 · Deleted

Register entry

Publication number
EP3199203
Application number
EP17160882
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Feb 27, 2009
Published
Aug 2, 2017
Granted
Feb 5, 2020
Deleted
Feb 29, 2020
Reason
Annual fee unpaid
IPC classes
A61P 13/12 (2006.01)
A61P 1/16 (2006.01)
C07D 473/06 (2006.01)
A61K 31/522 (2006.01)
Priority
US 67736 P 29.02.2008
US 134568 P 11.07.2008
US 198715 P 07.11.2008
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 23, 2020

    Deleted, fee unpaid

    Published in Swissreg on 23.09.2020

  2. Feb 5, 2020

    Granted

    Published in Swissreg on 05.02.2020

Parties

Holder

Concert Pharmaceuticals, Inc.

Concert Pharmaceuticals Inc.

65 Hayden Avenue, Suite 3000N, Lexington, MA 02421, US

Inventor

HARBESON, Scott, L.

Cambridge, MA Massachusetts 02140, US

TUNG, Roger, D.

Lexington, MA Massachusetts 02420, US

LIU, Julie, F.

Lexington, MA Massachusetts 02420, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.